%0 Generic
%A Garassino, M.
%A Cho, B. C.
%A Kim, J.
%A Mazieres, J.
%A Vansteenkiste, J.
%A Lena, H. H.
%A Corral, J.
%A Gray, J.
%A Powderly, J.
%A Chouaid, C.
%A Bidoli, P.
%A Wheatley-Price, P.
%A Park, K.
%A Soo, R.
%A Huang, Y.
%A Wadsworth, C.
%A Dennis, P.
%A Rizvi, N.
%T Safety of Durvalumab Retreatment in Advanced NSCLC Patients Who Progressed Following Initial Disease Control In ATLANTIC
%D 2018
%@ 1556-0864
%U https://hdl.handle.net/10668/27250
%K durvalumab
%K programmed cell death ligand-1
%K Immunotherapy
%~